首页> 外文OA文献 >Tackling antimicrobial resistance in lower urinary tract infections : treatment options
【2h】

Tackling antimicrobial resistance in lower urinary tract infections : treatment options

机译:解决下尿路感染中的抗菌药物耐药性:治疗方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Urinary tract infections (UTIs) are among the most common infectious diseases occurring ineither the community or healthcare settings. A wide variety of bacteria are responsible forcausing UTIs, however extra-intestinal pathogenic E. coli or ExPEC) remains the most commonetiological agent. Since 2000, resistance to antibiotics emerged globally among ExPEC and iscausing delays in appropriate therapy with subsequent increased morbidity and mortality. Forpatients with acute uncomplicated lower UTIs, nitrofurantoin, trimethoprim-sulfamethoxazole,fosfomycin or pivmecillinam should be prescribed for a 1-5 day course depending on the agentused. Single-dose fosfomycin is an excellent option for uncomplicated lower UTIs and has hadsimilar clinical and/or bacteriological efficacy for 3- or 7-day regimens for alternate agents (i.e.,ciprofloxacin, norfloxacin, cotrimoxazole or nitrofurantoin). The aim of this review article is toprovide an overview on the definitions, etiology, treatment guidelines (including agents for infections due to antimicrobial resistant bacteria) of lower UTIs and to highlight recent aspectson antimicrobial resistance of ExPEC.
机译:尿路感染(UTI)是在社区或医疗机构中最常见的传染病之一。引起UTI的原因多种多样,但是肠外致病性大肠杆菌(ExPEC)仍然是最常见的病原体。自2000年以来,ExPEC在全球范围内对抗生素产生了抗药性,导致适当治疗的延误,从而增加了发病率和死亡率。对于患有急性并发性较低尿路感染的患者,应根据所用的药物开具1-5天的疗程,以使用呋喃妥因,甲氧苄氨嘧啶,磺胺甲恶唑,磷霉素或吡维西南。单剂量磷霉素是不复杂的较低尿路感染的极佳选择,并且对于替代药物(即环丙沙星,诺氟沙星,cotrimoxazole或硝基呋喃妥因)的3天或7天方案具有相似的临床和/或细菌学疗效。这篇综述文章的目的是概述低尿路感染的定义,病因,治疗指南(包括用于抗微生物耐药细菌感染的药物),并重点介绍关于ExPEC的近期抗微生物方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号